Active Ingredient: BUPIVACAINE HYDROCHLORIDE
Proprietary Name: BUPIVACAINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.25%
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A217792
Product Number: 001
Approval Date: Nov 20, 2023
Applicant Holder Full Name: SOMERSET THERAPEUTICS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
Active Ingredient: BUPIVACAINE HYDROCHLORIDE
Proprietary Name: BUPIVACAINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.5%
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A217792
Product Number: 002
Approval Date: Nov 20, 2023
Applicant Holder Full Name: SOMERSET THERAPEUTICS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information